Skip to content

Rnaseh2b Related Type 1 Interferonopathy Cn377543

Published: July 22, 2026Updated: August 20, 2026

A genetic condition that causes the immune system to attack the body's own tissues. Treatment focuses on managing inflammation and symptoms.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
R69
ICD-11
MA00.0
Body system
immunologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Developmental delay

Generalized symptoms

(immunologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Intracranial calcifications

(immunologic)

Microcephaly

(immunologic)

Hepatosplenomegaly

(immunologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Drug therapy with clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

JAK Inhibitor Therapy

Targeted JAK inhibitor therapy reduces interferon-mediated inflammation by blocking downstream signaling of overactive interferon receptors. Treatment selection and dosing should be individualized based on disease severity and patient response.

medication
3

Immunomodulatory Therapy

Immunomodulatory agents may be used as adjunctive therapy to reduce overall inflammatory burden and allow for lower corticosteroid doses when combined.

medication

Additional treatment options

Neurological Surveillance

Regular neurological monitoring including developmental assessments, brain imaging, and neurophysiological studies to detect progressive involvement.

monitoring

Anti-inflammatory Nutritional Support

Dietary modifications emphasizing anti-inflammatory foods, adequate protein for muscle maintenance, and micronutrient supplementation may support overall disease management.

dietary

Integrative Supportive Care

Complementary approaches including stress reduction techniques, adequate sleep hygiene, and gentle exercise programs may help manage fatigue and improve quality of life.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Rnaseh2b Related Type 1 Interferonopathy Cn377543?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Crow YJ, Manel N. Aicardi-Goutières syndrome and the type I interferonopathies. Nat Rev Immunol. 2015.

review2015
2

Rice GI, et al. International Consensus Guidelines for the Diagnosis and Management of Type I Interferonopathies. J Clin Immunol. 2022.

guideline2022
3

Hasan Z, et al. RNASEH2B-Related Disease: Clinical Manifestations and Treatment Outcomes. Neurology. 2020.

other2020
4

Fazzi EM, et al. Meta-Analysis of Interferon Signature in Aicardi-Goutières Syndrome and Related Conditions. Ann Rheum Dis. 2021.

meta_analysis2021

Medication Comparisons

Compare medications used to treat Rnaseh2b Related Type 1 Interferonopathy Cn377543. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy